Articles published by Kirby McInerney LLP



Kirby McInerney LLP Announces Investigation of Shareholder Claims Against Globus Medical, Inc. (GMED)
August 16, 2024
From Kirby McInerney LLP
Via Business Wire
Tickers
GMED

Kirby McInerney LLP Announces Investigation of Shareholder Claims Against Spire Global, Inc. (SPIR)
August 16, 2024
From Kirby McInerney LLP
Via Business Wire
Tickers
SPIR

Kirby McInerney LLP Announces Investigation of Shareholder Claims Against Cardlytics, Inc. (CDLX)
August 12, 2024
From Kirby McInerney LLP
Via Business Wire
Tickers
CDLX







Kirby McInerney LLP Announces Investigation of Shareholder Claims Against Paragon 28, Inc. (FNA)
August 01, 2024
From Kirby McInerney LLP
Via Business Wire
Tickers
FNA

Kirby McInerney LLP Announces Investigation of Shareholder Claims Against Centuri Holdings, Inc. (CTRI)
August 01, 2024
From Kirby McInerney LLP
Via Business Wire
Tickers
CTRI

Kirby McInerney LLP Announces Investigation of Shareholder Claims Against Medpace Holdings, Inc. (MEDP)
August 01, 2024
From Kirby McInerney LLP
Via Business Wire
Tickers
MEDP



Kirby McInerney LLP Announces Investigation of Shareholder Claims Against MaxLinear, Inc. (MXL)
July 26, 2024
From Kirby McInerney LLP
Via Business Wire
Tickers
MXL


Kirby McInerney LLP Announces Investigation of Shareholder Claims Against DexCom, Inc. (DXCM)
July 26, 2024
From Kirby McInerney LLP
Via Business Wire
Tickers
DXCM





Kirby McInerney LLP Announces Investigation of Shareholder Claims Against Metagenomi, Inc. (MGX)
July 17, 2024
From Kirby McInerney LLP
Via Business Wire
Tickers
MGX





Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.
Never miss important news. Subscribe to our newsletter.
Register for free